You can't buy biotech stocks at this time and feel comfortable. It does not seem to matter how much cash flow or earnings are at this time - their future appears to uncertain. The short term outlook is questionable at best. Good luck to the long term holders.
Thanks for your response. Free cash flow is one of the most important measurements of the true worth of a company and that is the main reason I am back in this stock. Good luck on your investment. Jefferies initiated coverage on Horizon Pharma plc (HZNP) this date with an initial rating of “Buy”. Possibly this will help us a little on Monday.
Yahoo indicates earnings estimates at $2.32 and $2.65 for 2016 and 2017. Does anyone have idea what the GAAP estimate is from these same analysts. The shares appear rediculously cheap if these estimates are anywhere near the acctual numbers. All responses appreciated.